Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.

Am J Gastroenterol · 2023 · PMC10617666 · PMID 37307528

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All GSRS and GIQLI domain scores showed a trend of progressive improvement from V0 to V3 in both treatment groups, except for the GSRS reflux domain in the omeprazole group (see Supplementary Digital Figure S2, http://links.lww.com/AJG/C969 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.